Bradford J Shafer
CIK 1302448 · EVP, Gen. Counsel, Secretary · last filed 2021-08-24
Bradford J Shafer is an EVP, Gen. Counsel, Secretary who has filed 87 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing shows the insider had shares withheld for taxes covering $60.5K of TBPH on Aug 24, 2021. Across all open-market trades the lifetime net is −$11.0M, making them a net seller over the disclosed history. 53 SEC filings were submitted jointly with Innoviva, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
THRX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SOUTH SAN FRANCISCO, CA 94080
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) Delisted | EVP, Gen. Counsel, Secretary | 277,831 | $17.03 | $4.73M | -$4.06M | 43 | 2021-08-24 |
| Innoviva, Inc. (THRX) Delisted | Sr VP, Gen. Counsel, Secretary | 445,763 | $4.06 | $1.81M | -$6.98M | 44 | 2014-08-22 |
Recent Filings
87 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-08-24 | Theravance Biopharma, Inc. (TBPH) Delisted | Tax (F) | −4,307 | -$60.5K | EDGAR |
| 2021-05-24 | Theravance Biopharma, Inc. (TBPH) Delisted | Tax (F) | −4,310 | -$76.7K | EDGAR |
| 2021-02-23 | Theravance Biopharma, Inc. (TBPH) Delisted | Tax (F) | −31,869 | -$598.8K | EDGAR |
| 2021-02-10 | Theravance Biopharma, Inc. (TBPH) Delisted | Grant (A) | +65,000 | $0 | EDGAR |
| 2020-11-24 | Theravance Biopharma, Inc. (TBPH) Delisted | Tax (F) | −4,807 | -$82.7K | EDGAR |
| 2020-08-24 | Theravance Biopharma, Inc. (TBPH) Delisted | Tax (F) | −4,804 | -$87.5K | EDGAR |
| 2020-05-22 | Theravance Biopharma, Inc. (TBPH) Delisted | Tax (F) | −4,807 | -$128.2K | EDGAR |
| 2020-02-24 | Theravance Biopharma, Inc. (TBPH) Delisted | Tax (F) | −29,402 | -$761.5K | EDGAR |
| 2020-02-05 | Theravance Biopharma, Inc. (TBPH) Delisted | Grant (A) | +119,000 | $0 | EDGAR |
| 2019-11-22 | Theravance Biopharma, Inc. (TBPH) Delisted | Tax (F) | −3,567 | -$62.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.